ATRIUM ACQUIRES DOUGLAS LABORATORIES CANADA

Atrium Biotechnologies Inc. is pleased to announce the acquisition of the assets of London, Ontario-based Douglas Laboratories Canada ("DL Canada"). DL Canada has been marketing Douglas Laboratories products in Canada since 2000 and has current annual revenues of approximately $5 million. Yahoo Finance (http://biz.yahoo.com/prnews/060911/mo452.html?.v=1)